Chengdu Sun
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
-
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
-
- Metabolism, Diabetes, and Cancer 2
- Co-authors
- Qingzhu Jia (6 shared papers)Bo Zhu (6 shared papers)Zhihua Gong (6 shared papers)Jianan Cheng (6 shared papers)Yi Feng (3 shared papers)Ying Dai (3 shared papers)Peter B. Alexander (2 shared papers)Yisong Y. Wan (2 shared papers)
- Journals
- Nature Communications (1 paper)Cancer Medicine (1 paper)Frontiers in Immunology (1 paper)Journal of Cellular and Molecular Medicine (1 paper)Nanoscale (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chengdu Sun
9 papers receiving 588 citations
Peers
Comparison fields: 5 of 51
- Oncology 244
- Cancer Research 131
- Immunology 127
- Pulmonary and Respiratory Medicine 156
- Molecular Biology 165
Countries citing papers authored by Chengdu Sun
This map shows the geographic impact of Chengdu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengdu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengdu Sun more than expected).
Fields of papers citing papers by Chengdu Sun
This network shows the impact of papers produced by Chengdu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengdu Sun. The network helps show where Chengdu Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengdu Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 320 | |
| 2 | 2018 | 138 | |
| 3 | 2021 | 46 | |
| 4 | 2018 | 33 | |
| 5 | 2018 | 16 | |
| 6 | 2019 | 10 | |
| 7 | 2016 | 10 | |
| 8 | 2018 | 10 | |
| 9 | 2020 | 8 |
About Chengdu Sun
Chengdu Sun is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Organic Chemistry, having authored 9 papers that have together received 591 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer, Lipids, and Metabolism (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Cancer Genomics and Diagnostics (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Fullerene Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (244 citations), Cancer Research (131 citations), Immunology (127 citations), Pulmonary and Respiratory Medicine (156 citations) and Molecular Biology (165 citations). Chengdu Sun has collaborated with scholars based in China and United States. Frequent co-authors include Qingzhu Jia, Bo Zhu, Zhihua Gong, Jianan Cheng, Yi Feng, Ying Dai, Peter B. Alexander, Yisong Y. Wan, Yuqi Wang and Huaibo Sun. Their work appears in journals such as Nature Communications, Cancer Medicine, Frontiers in Immunology, Journal of Cellular and Molecular Medicine and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.